Growth Metrics

Insulet (PODD) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 13.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.02%
Dec 31, 2025 -20.01%
Sep 30, 2025 2.94%
Jun 30, 2025 -2.09%
Mar 31, 2025 30.71%
Dec 31, 2024 -23.16%
Sep 30, 2024 -33.92%
Jun 30, 2024 -29.75%
Mar 31, 2024 -1.87%
Dec 31, 2023 23.03%
Sep 30, 2023 -118.07%
Jun 30, 2023 -32.83%
Mar 31, 2023 -72.60%
Dec 31, 2022 -17.86%
Sep 30, 2022 -68.44%
Jun 30, 2022 17.78%
Mar 31, 2022 -101.42%
Dec 31, 2021 3.72%
Sep 30, 2021 22.90%
Jun 30, 2021 42.86%
Mar 31, 2021 25.99%
Dec 31, 2020 22.58%
Sep 30, 2020 -0.98%
Jun 30, 2020 71.65%
Mar 31, 2020 32.32%
Dec 31, 2019 17.79%
Sep 30, 2019 31.44%
Jun 30, 2019 -1.90%
Mar 31, 2019 73.55%
Dec 31, 2018 -127.10%
Sep 30, 2018 -54.34%
Jun 30, 2018 -521.16%
Mar 31, 2018 -134.42%
Dec 31, 2017 -284.19%
Sep 30, 2017 42.52%
Jun 30, 2017 -82.97%
Mar 31, 2017 -169.64%
Dec 31, 2016 -226.58%
Sep 30, 2016 -191.30%
Jun 30, 2016 -183.99%
Mar 31, 2016 49.78%
Dec 31, 2015 -19.22%
Sep 30, 2015 -15.60%
Jun 30, 2015 53.58%
Mar 31, 2015 -36.76%
Dec 31, 2014 -4.98%
Sep 30, 2014 1.76%
Jun 30, 2014 55.43%
Mar 31, 2014 9.36%
Dec 31, 2013 1.47%
Sep 30, 2013 -3.44%